Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs MDY✓SelectedUSD · MDYGSK vs MDY performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs MDY

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
MDY return
+141.4%
Excess return
-44.3%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMDYExcessAlpha
1D-0.1%-2.6%+2.5%+0.9%
7D-5.3%-6.9%+1.6%-2.8%
30D-3.7%-6.5%+2.8%-1.3%
3M-7.3%-9.9%+2.6%-3.7%
6M-4.2%-5.3%+1.1%-2.5%
YTD+0.9%+4.5%-3.7%-1.1%
1Y+7.3%+11.3%-4.0%+2.7%
3Y+52.7%+39.2%+13.5%+32.1%
5Y+40.1%+27.1%+13.0%+23.8%
All+97.1%+141.4%-44.3%+29.7%

Cumulative growth

Daily Returns

Daily percentage return beside MDY.

Daily Out/Under-Performance

Portfolio return minus MDY return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MDY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MDY wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling